Early Cytokine Surge in Secondary Dengue Infections Offers Clues for Better Diagnosis

Dengue News: A recent study has uncovered critical insights into the body's immune response to dengue infection, particularly highlighting how cytokines - proteins that play a pivotal role in the immune system - behave differently in primary and secondary dengue infections. Led by researchers from the Instituto de Biología Subtropical (IBS), Academia Nacional de Medicina, and other prestigious institutions in Argentina, the study focuses on the importance of interleukins IL-6 and IL-10 in the febrile stage of dengue infection.


Early Cytokine Surge in Secondary Dengue Infections Offers Clues for Better Diagnosis

The findings could have a significant impact on how dengue cases are diagnosed and managed, especially in patients who are experiencing a secondary infection. Elevated levels of IL-6 and IL-10 were found to occur earlier in secondary infections, providing a potential tool for early intervention in severe cases.
 
What the Study Involves
The research, conducted between 2016 and 2020, involved analyzing serum and plasma samples from 259 dengue-infected patients. These samples were collected during outbreaks in Argentina and classified based on the phase of infection and the presence of specific antibodies. This Dengue News report outlines the main findings and significance of these cytokine changes in relation to clinical outcomes, offering new pathways for predicting disease progression.

The study primarily aimed to understand the kinetics of IL-6 and IL-10 levels during dengue virus infections, particularly during the early febrile phase when most patients begin to exhibit symptoms.
 
Secondary Infections Show Earlier Cytokine Response
One of the standout findings of the research is that patients experiencing a secondary dengue infection - meaning they had been previously infected with a different strain of the virus - showed an earlier elevation of IL-6 and IL-10 compared to those with primary infections.
 
For context, IL-6 is a pro-inflammatory cytokine that is involved in the body's response to infection, while IL-10 has anti-inflammatory properties. Their levels were significantly higher in secondary infections during the first phase of the febrile stage, which typically begins shortly after the onset of symptoms.
 
In contrast, primary infections generally showed elevated cytokine levels later in the febrile stage. This early surge of cytokines in secondary infections suggests that the immune system is primed for a faster response due to the memory of the previous infection. However, this rapid response may also contribute to severe symptoms, as the immune system can overreact, leading to complications such as thrombocytopenia (low platelet count) and liver damage.
 
Clinical Relevance: A Potential Biomarker for Severe Dengue
This early cytokine surge could serve as a biomarker for identifying patients at risk of severe dengue, particularly in those with secondary infections. Elevated IL-6 and IL-10 levels were associated with a higher likelihood of hospitalization, liver damage, and severe thrombocytopenia, which are all indicators of a more severe disease course.
 
The study found that nearly 40% of the patients analyzed were experiencing a secondary infection, and these individuals were more likely to develop severe complications. Additionally, among the patients who required hospitalization, elevated levels of IL-6 and IL-10 were frequently observed, alongside higher liver enzyme levels and lower platelet counts.
 
Thrombocytopenia and Liver Dysfunction: Key Indicators of Severity
Thrombocytopenia, defined as a platelet count below 100,000/µL, is one of the hallmark features of severe dengue infections. The study revealed that patients in the later phase of the febrile stage (Phase II) and those with secondary infections were significantly more likely to develop thrombocytopenia. Elevated IL-6 and IL-10 levels were also closely correlated with low platelet counts in these patients.
 
Furthermore, liver damage, as indicated by elevated aspartate transaminase (AST) levels, was more common in Phase II patients. Liver dysfunction is a common complication in severe dengue and can exacerbate other symptoms such as bleeding and shock. The researchers suggest that monitoring cytokine levels, in conjunction with liver function tests, could provide valuable insights into disease progression and help guide treatment decisions.
 
Hospitalization and Cytokine Levels
The study also examined the characteristics of the 26 patients (10% of the total cohort) who required hospitalization due to severe complications from dengue. On average, these patients were 15 years older than those who were treated as outpatients, and they were more likely to have thrombocytopenia and elevated AST levels. Importantly, they also exhibited higher IL-6 levels compared to non-hospitalized patients.
 
This finding suggests that IL-6 could be a critical marker for identifying patients at risk of hospitalization. By tracking cytokine levels early in the disease course, healthcare providers could potentially intervene earlier to prevent severe complications.
 
Conclusion: Towards Better Management of Dengue Infections
In conclusion, the study underscores the importance of understanding cytokine dynamics in dengue infections. By identifying an early cytokine surge in secondary infections, the research offers a potential pathway for improving the diagnosis and management of dengue, particularly in patients at risk of developing severe complications.
 
While this study focused on IL-6 and IL-10, the researchers note that further investigations involving a broader panel of cytokines could provide even deeper insights into the immune response to dengue. The early identification of patients who are likely to develop severe symptoms could enable more targeted interventions, potentially reducing the need for hospitalization and improving patient outcomes.
 
Future Research
The study lays the groundwork for future research that could explore the role of other cytokines and immune factors in the progression of dengue. Additionally, a longitudinal study that tracks patients over the course of their illness could provide even more robust data on how cytokine levels change and influence clinical outcomes.
 
This type of research could ultimately lead to the development of new diagnostic tools and treatments that are better suited to managing dengue infections, particularly in regions where the disease is endemic.
 
The study findings were published in the peer-reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/25/20/11238
 
For the latest Dengue News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/taiwanese-murine-study-shows-that-dengue-virus-envelope-protein-causes-dangerous-hemorrhage-and-endothelial-cell-death
 
https://www.thailandmedical.news/news/taiwanese-study-finds-that-hernandonine-from-hernandia-nymphaeifolia-can-be-used-to-combat-the-dengue-virus